Glatiramer Dosage

Medically reviewed on May 8, 2018.

Usual Adult Dose for Multiple Sclerosis

20 mg subcutaneously once a day or 40 mg subcutaneously 3 times a week

Comments:
-For the 3 times a week dosage regimen, each dose must be separated by at least 48 hours.
-Length of treatment should be individualized.

Approved indication: For the treatment of patients with relapsing forms of multiple sclerosis

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

General:
-Because this drug can modify immune response, it could possibly interfere with useful immune function.
-Injection sites should be rotated.
-This drug should only be administered subcutaneously, not IV or IM.
-The initiation of treatment should be supervised by a neurologist or a physician experienced in the treatment of MS.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer